Evaluation of the Effects of Platelet-Rich Plasma on Follicular and Endometrial Growth: A Literature Review

Adrielli Riboldi Ferrari, Sylvia Cortrezzi, Edson Borges Junior, Daniela Braga, Maria do Carmo Borges de Souza, Roberto de Azevedo Antunes, Adrielli Riboldi Ferrari, Sylvia Cortrezzi, Edson Borges Junior, Daniela Braga, Maria do Carmo Borges de Souza, Roberto de Azevedo Antunes

Abstract

Platelet-rich plasma (PRP) has been used in several areas of medicine due to its ability to promote tissue regeneration by growth factors and cytokines. This review addresses the use of PRP to rejuvenate ovarian follicles and increase the thickness of the endometrium to receive an embryo. PRP is obtained from the patient's own blood (autologous blood) - a fact that determines a lower chance of rejection reactions. Alpha granules of platelets provide and release supra physiological amounts of growth factors and cytokines, which provide a regenerative stimulus in tissues with low healing potential. In the ovary, PRP and its growth factors stimulate vascularization and recruitment of available primordial follicles that could no longer be otherwise stimulated. The rejuvenation of the ovary by PRP infusion aims to obtain new oocytes in ovaries with low numbers of follicles or low follicular reserve markers. In the preparation of the endometrium, PRP is used for its several growth factors that allow tissue proliferation and endometrial thickening, especially in cases of endometria that are difficult to prepare or that fail to reach an adequate minimum thickness (>7mm). To date, there are few studies of greater expression in the literature that support the use of PRP with the two purposes described above. Thus, although promising, the technique must still be validated by larger clinical trials.

Keywords: platelet-rich plasma; review.

Conflict of interest statement

CONFLICT OF INTERESTS

The authors have no conflict of interest to declare.

Figures

Figure 1
Figure 1
Most common growth factors in PRP and their main functions.

References

    1. Aghajanova L, Hoffman J, Mok-Lin E, Herndon CN. Obstetrics and Gynecology Residency and Fertility Needs. Reprod Sci. 2017;24:428–434. doi: 10.1177/1933719116657193.
    1. Alam F, Khan TA, Amjad S, Rehman R. Association of oxidative stress with female infertility - A case control study. J Pak Med Assoc. 2019;69:627–631.
    1. Borzini P, Mazzucco I. Platelet-rich plasma (PRP) and platelet derivatives for topical therapy. What is true from the biologic view point? ISBT Sci Ser. 2007;2:272–281.
    1. Bos-Mikich A, de Oliveira R, Frantz N. Platelet-rich plasma therapy and reproductive medicine. J Assist Reprod Genet. 2018;35:753–756. doi: 10.1007/s10815-018-1159-8.
    1. Brazil. Ministry of Health. ANVISA . SisEmbrio - 12th SisEmbrio report. Brasília: ANVISA; 2020. Portuguese.
    1. Britt JH. Oocyte development in cattle: physiological and genetic aspects. Rev Bras Zootec. 2008;37:110–115. doi: 10.1590/S1516-35982008001300013.
    1. Casati L, Celotti F, Negri-Cesi P, Sacchi MC, Castano P, Colciago A. Platelet derived growth factor (PDGF) contained in Platelet Rich Plasma (PRP) stimulates migration of osteoblasts by reorganizing actin cytoskeleton. Cell Adh Migr. 2014;8:595–602. doi: 10.4161/19336918.2014.972785.
    1. Chang Y, Li J, Chen Y, Wei L, Yang X, Shi Y, Liang X. Autologous platelet-rich plasma promotes endometrial growth and improves pregnancy outcome during in vitro fertilization. Int J Clin Exp Med. 2015;8:1286–1290.
    1. Coksuer H, Akdemir Y, Ulas Barut M. Improved in vitro fertilization success and pregnancy outcome with autologous platelet-rich plasma treatment in unexplained infertility patients that had repeated implantation failure history. Gynecol Endocrinol. 2019;35:815–818. doi: 10.1080/09513590.2019.1597344.
    1. Colombo GVL, Fanton V, Sosa D, Criado Scholz E, Lotti J, Aragona SE, Lotti T. Use of platelet rich plasma in human infertility. J Biol Regul Homeost Agents. 2017;31:179–182.
    1. Davis VL, Abukabda AB, Radio NM, Witt-Enderby PA, Clafshenkel WP, Cairone JV, Rutkowski JL. Platelet-rich preparations to improve healing. Part I: workable options for every size practice. J Oral Implantol. 2014;40:500–510. doi: 10.1563/AAID-JOI-D-12-00104.
    1. Dawood AS, Salem HA. Current clinical applications of platelet-rich plasma in various gynecological disorders: An appraisal of theory and practice. Clin Exp Reprod Med. 2018;45:67–74. doi: 10.5653/cerm.2018.45.2.67.
    1. DeLong JM, Russell RP, Mazzocca AD. Platelet-rich plasma: the PAW classification system. Arthroscopy. 2012;28:998–1009. doi: 10.1016/j.arthro.2012.04.148.
    1. Deochand C, Tong M, Agarwal AR, Cadenas E, de la Monte SM. Tobacco Smoke Exposure Impairs Brain Insulin/IGF Signaling: Potential Co-Factor Role in Neurodegeneration. J Alzheimers Dis. 2016;50:373–386. doi: 10.3233/JAD-150664.
    1. Dhurat R, Sukesh M. Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author's Perspective. J Cutan Aesthet Surg. 2014;7:189–197. doi: 10.4103/0974-2077.150734.
    1. Du L, Miao Y, Li X, Shi P, Hu Z. A Novel and Convenient Method for the Preparation and Activation of PRP without Any Additives: Temperature Controlled PRP. Biomed Res Int. 2018;2018:1761865–1761865. doi: 10.1155/2018/1761865.
    1. Fabi S, Sundaram H. The potential of topical and injectable growth factors and cytokines for skin rejuvenation. Facial Plast Surg. 2014;30:157–171. doi: 10.1055/s-0034-1372423.
    1. Facchin F, Somigliana E, Busnelli A, Catavorello A, Barbara G, Vercellini P. Infertility-related distress and female sexual function during assisted reproduction. Hum Reprod. 2019;34:1065–1073. doi: 10.1093/humrep/dez046.
    1. Fang J, Wang X, Jiang W, Zhu Y, Hu Y, Zhao Y, Song X, Zhao J, Zhang W, Peng J, Wang Y. Platelet-Rich Plasma Therapy in the Treatment of Diseases Associated with Orthopedic Injuries. Tissue Eng Part B Rev. 2020;26:571–585. doi: 10.1089/ten.teb.2019.0292.
    1. Farimani M, Bahmanzadeh M, Poorolajal J. A New Approach Using Autologous Platelet-Rich Plasma (PRP) to Treat Infertility and To Improve Population Replacement Rate. J Res Health Sci. 2016;16:172–173.
    1. Farimani M, Heshmati S, Poorolajal J, Bahmanzadeh M. A report on three live births in women with poor ovarian response following intra-ovarian injection of platelet-rich plasma (PRP) Mol Biol Rep. 2019;46:1611–1616. doi: 10.1007/s11033-019-04609-w.
    1. Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L, ESHRE working group on Poor Ovarian Response Definition ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26:1616–1624. doi: 10.1093/humrep/der092.
    1. Gonçalves LF, Fernandes AP, Cosme-Silva L, Colombo FA, Martins NS, Oliveira TM, Araujo TH, Sakai VT. Effect of EDTA on TGF-β1 released from the dentin matrix and its influence on dental pulp stem cell migration. Braz Oral Res. 2016;30:e131. doi: 10.1590/1807-3107bor-2016.vol30.0131.
    1. Grassi EA, Araujo MC. Antiplatelet: Growing knowledge. Disc Scientia. 2012;13:131–143.
    1. Haahr T, Esteves SC, Humaidan P. Individualized controlled ovarian stimulation in expected poor-responders: an update. Reprod Biol Endocrinol. 2018;16:20–20. doi: 10.1186/s12958-018-0342-1.
    1. Jang HY, Myoung SM, Choe JM, Kim T, Cheon YP, Kim YM, Park H. Effects of Autologous Platelet-Rich Plasma on Regeneration of Damaged Endometrium in Female Rats. Yonsei Med J. 2017;58:1195–1203. doi: 10.3349/ymj.2017.58.6.1195.
    1. Jo CH, Roh YH, Kim JE, Shin S, Yoon KS. Optimizing platelet-rich plasma gel formation by varying time and gravitational forces during centrifugation. J Oral Implantol. 2013;39:525–532. doi: 10.1563/AAID-JOI-D-10-00155.
    1. Kahraman S, Cetinkaya CP, Cetinkaya M, Yelke H, Colakoglu YK, Aygun M, Montag M. The effect of follicle size and homogeneity of follicular development on the morphokinetics of human embryos. J Assist Reprod Genet. 2017;34:895–903. doi: 10.1007/s10815-017-0935-1.
    1. Kim H, Shin JE, Koo HS, Kwon H, Choi DH, Kim JH. Effect of Autologous Platelet-Rich Plasma Treatment on Refractory Thin Endometrium During the Frozen Embryo Transfer Cycle: A Pilot Study. Front Endocrinol (Lausanne) 2019;10:61–61. doi: 10.3389/fendo.2019.00061.
    1. Lichtenfels M. Efeito do Plasma Rico em Plaquetas e de Plaquetas Rica em Fibrina na Regeneração de Lesões com Perda de Substância do Nervo Ciático em Ratos. Porto Alegre: Pontifícia Universidade Católica do Rio Grande do Sul; 2012. Dissertation.
    1. Malanga GA, Goldin M. PRP: review of the current evidence for musculoskeletal conditions. Curr Phys Med Rehabil Rep. 2014;2:1–5. doi: 10.1007/s40141-013-0039-5.
    1. Mazzucco L, Balbo V, Cattana E, Guaschino R, Borzini P. Not every PRP-gel is born equal. Evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet, RegenPRP-Kit, Plateltex and one manual procedure. Vox Sang. 2009;97:110–118. doi: 10.1111/j.1423-0410.2009.01188.x.
    1. Mishra A, Harmon K, Woodall J, Vieira A. Sports medicine applications of platelet rich plasma. Curr Pharm Biotechnol. 2012;13:1185–1195. doi: 10.2174/138920112800624283.
    1. Molina A, Sánchez J, Sánchez W, Vielma V. Platelet-rich plasma as an adjuvant in the endometrial preparation of patients with refractory endometrium. JBRA Assist Reprod. 2018;22:42–48. doi: 10.5935/1518-0557.20180009.
    1. Nayak S, Dinda A. Lower level laser therapy for pain management: an integrative review. Caribb J Sci Technol. 2015;3:744–751.
    1. Noyes N, Liu HC, Sultan K, Schattman G, Rosenwaks Z. Endometrial thickness appears to be a significant factor in embryo implantation in in-vitro fertilization. Hum Reprod. 1995;10:919–922. doi: 10.1093/oxfordjournals.humrep.a136061.
    1. Pantos K, Simopoulou M, Pantou A, Rapani A, Tsioulou P, Nitsos N, Syrkos S, Pappas A, Koutsilieris M, Sfakianoudis K. A Case Series on Natural Conceptions Resulting in Ongoing Pregnancies in Menopausal and Prematurely Menopausal Women Following Platelet-Rich Plasma Treatment. Cell Transplant. 2019;28:1333–1340. doi: 10.1177/0963689719859539.
    1. Roh YH, Kim W, Park KU, Oh JH. Cytokine-release kinetics of platelet-rich plasma according to various activation protocols. Bone Joint Res. 2016;5:37–45. doi: 10.1302/2046-3758.52.2000540.
    1. Scherer SS, Tobalem M, Vigato E, Heit Y, Modarressi A, Hinz B, Pittet B, Pietramaggiori G. Nonactivated versus thrombin-activated platelets on wound healing and fibroblast-to-myofibroblast differentiation in vivo and in vitro. Plast Reconstr Surg. 2012;129:46e–54e. doi: 10.1097/PRS.0b013e3182362010.
    1. Seyyed Anvari S, Dehgan GH, Razi M. Preliminary Findings of Platelet-Rich Plasma-Induced Ameliorative Effect on Polycystic Ovarian Syndrome. Cell J. 2019;21:243–252. doi: 10.22074/cellj.2019.5952.
    1. Sfakianoudis K, Simopoulou M, Nitsos N, Rapani A, Pantou A, Vaxevanoglou T, Kokkali G, Koutsilieris M, Pantos K. A Case Series on Platelet-Rich Plasma Revolutionary Management of Poor Responder Patients. Gynecol Obstet Invest. 2019;84:99–106. doi: 10.1159/000491697.
    1. Sills ES, Wood SH. Autologous activated platelet-rich plasma injection into adult human ovary tissue: molecular mechanism, analysis, and discussion of reproductive response. Biosci Rep. 2019;39:BSR20190805–BSR20190805. doi: 10.1042/BSR20190805.
    1. Tarín JJ, García-Pérez MA, Hamatani T, Cano A. Infertility etiologies are genetically and clinically linked with other diseases in single meta-diseases. Reprod Biol Endocrinol. 2015;13:31–31. doi: 10.1186/s12958-015-0029-9.
    1. Zadehmodarres S, Salehpour S, Saharkhiz N, Nazari L. Treatment of thin endometrium with autologous platelet-rich plasma: a pilot study. JBRA Assist Reprod. 2017;21:54–56. doi: 10.5935/1518-0557.20170013.
    1. Zegers-Hochschild F, Schwarze JE, Crosby JA, Musri C, Urbina MT. Assisted reproductive techniques in Latin America: The Latin American registry, 2016. JBRA Assist Reprod. 2019;23:255–267. doi: 10.5935/1518-0557.20190037.
    1. Zhang X, Wang J, Ren M, Li L, Wang Q, Hou X. A novel collagen/platelet-rich plasma (COL/PRP) scaffold: preparation and growth factor release analysis. Cell Tissue Bank. 2016;17:327–334. doi: 10.1007/s10561-016-9551-z.
    1. Zhou J, Peng X, Mei S. Autophagy in Ovarian Follicular Development and Atresia. Int J Biol Sci. 2019;15:726–737. doi: 10.7150/ijbs.30369.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅